These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3486877)

  • 1. Absence of effect of 24,25-dihydroxyvitamin D3 in primary hyperparathyroidism.
    Netelenbos JC; Asscheman H; Lips P; Van der Vijgh WJ; Jongen MJ; Van Ginkel F; Hackeng WH
    J Clin Endocrinol Metab; 1986 Jul; 63(1):246-8. PubMed ID: 3486877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of effect of 24,25-dihydroxycholecalciferol on serum immunoreactive PTH in patients with persistent hyperparathyroidism after renal transplantation.
    Friedlander MA; Horst RL; Hawker CD
    Clin Nephrol; 1984 Oct; 22(4):206-10. PubMed ID: 6391769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.
    Bouillon R; Muls E; De Moor P
    J Clin Endocrinol Metab; 1980 Oct; 51(4):793-7. PubMed ID: 6893457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of 1,25-dihydroxycholecalciferol on parathyroid activity in patients with primary hyperparathyroidism.
    Holmlund D; Boquist L; Larsson SE; Lorentzon R
    Acta Chir Scand; 1979; 145(1):27-33. PubMed ID: 433514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary hyperparathyroidism with 1,25-dihydroxyvitamin D deficiency and pseudohypoparathyroidism in childhood: relationship between plasma 1,25-dihydroxyvitamin D and parathyroid hormone levels and urinary cyclic AMP response to exogenous PTH.
    Seino Y; Ishida M; Yamaoka K; Shimotsuji T; Ishii T; Yabuuchi H; Fukase M; Fujita T
    Eur J Pediatr; 1981 Feb; 135(3):267-71. PubMed ID: 6262082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of 24,25-dihydroxyvitamin D3 administration on parameters of calcium metabolism.
    Harvey JA; Zerwekh JE; Sakhaee K; Pak CY
    J Clin Endocrinol Metab; 1989 Aug; 69(2):467-9. PubMed ID: 2787802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of 1alpha,25-dihydroxyvitamin D3 to hypocalcemia in human subjects.
    Bilezikian JP; Canfield RE; Jacobs TP; Polay JS; D'Adamo AP; Eisman JA; DeLuca HF
    N Engl J Med; 1978 Aug; 299(9):437-41. PubMed ID: 210383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D metabolism during recovery from severe osteitis fibrosa cystica of primary hyperparathyroidism.
    Gonzalez-Villapando C; Porath A; Berelowitz M; Marshall L; Favus MJ
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1180-3. PubMed ID: 6893459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of 24,25-dihydroxyvitamin D3 in humans.
    Jongen M; van der Vijgh WJ; Netelenbos JC; Postma GJ; Lips P
    Horm Metab Res; 1989 Oct; 21(10):577-80. PubMed ID: 2807147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hypophosphatemic rickets: growth acceleration after long-term treatment with 1,25-dihydroxyvitamin-D3.
    Chan JC; Lovinger RD; Mamunes P
    Pediatrics; 1980 Sep; 66(3):445-54. PubMed ID: 6893489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria.
    Van Den Berg CJ; Kumar R; Wilson DM; Heath H; Smith LH
    J Clin Endocrinol Metab; 1980 Nov; 51(5):998-1001. PubMed ID: 6893460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of acute effects of 1.25- and 24.25-dihydroxy-vitamin D3 in normal subjects.
    Heynen G; Cornet F; Franchimont P; Gaspar S; Plomteux G; Cession-Fossion G; Russel RG; Kanis JA
    Acta Endocrinol (Copenh); 1981 Dec; 98(4):619-24. PubMed ID: 6975547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
    Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
    J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with active vitamin D (alphacalcidol) in patients with mild primary hyperparathyroidism.
    Lind L; Wengle B; Sørensen OH; Wide L; Akerström G; Ljunghall S
    Acta Endocrinol (Copenh); 1989 Feb; 120(2):250-6. PubMed ID: 2644746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis.
    Lawoyin S; Zerwekh JE; Glass K; Pak CY
    J Clin Endocrinol Metab; 1980 Mar; 50(3):593-6. PubMed ID: 6965678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hypocalciuric hypercalcaemia: observations on vitamin D metabolism and parathyroid function.
    Davies M; Adams PH; Berry JL; Lumb GA; Klimiuk PS; Mawer EB; Wain D
    Acta Endocrinol (Copenh); 1983 Oct; 104(2):210-5. PubMed ID: 6314724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.